Wyeth Must Pay for their Defective Drugs

Greg Owen

Attorney

0 CommentsPrint ArticleSubscribe

On October 12, Reno jurors decided that Wyeth, the largest maker of hormone-replacement medicines, must pay $134.1 million, including $99 million in punitive damages. This suit was filed due to the mishandling of menopause drugs that helped cause cancer in three women. The punitive damages were levied on Wyeth for concealing the breast-cancer risks of its Prempro and Premarin drugs.

Some six million women took the drugs to treat symptoms of menapause. The company has annual sales of more than $2 billion. While the increase for breast cancer in women taking the drug was a high as 24 percent. Wyeth have promised that they will appeal the verdict.

More information on defective and dangerous drugs